clorgyline has been researched along with Smoking Cessation in 1 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
Smoking Cessation: Discontinuing the habit of SMOKING.
Excerpt | Relevance | Reference |
---|---|---|
"There have been many reports of monoamine oxidase (MAO) inhibition by non-nicotine ingredients in tobacco smoke, persisting for days after smoking cessation." | 3.79 | Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat. ( Barclay, E; Goyarzu, P; Magallanes, N; Malin, DH; Mathews, H; Mills, WR; Moon, WD; Negrete, AP; Stephens, B; Vela, AJ, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Malin, DH | 1 |
Moon, WD | 1 |
Goyarzu, P | 1 |
Barclay, E | 1 |
Magallanes, N | 1 |
Vela, AJ | 1 |
Negrete, AP | 1 |
Mathews, H | 1 |
Stephens, B | 1 |
Mills, WR | 1 |
1 other study available for clorgyline and Smoking Cessation
Article | Year |
---|---|
Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
Topics: Animals; Brain; Clorgyline; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; | 2013 |